12-Year-Old Boy With Chronic Budd-Chiari Syndrome, Presenting With Recurrent Abdominal Pain and Distention, After Undergoing Left Hepatic Vein Angioplasty.

12-Year-Old Boy With Chronic Budd-Chiari Syndrome, Presenting With Recurrent Abdominal Pain and Distention, After Undergoing Left Hepatic Vein Angioplasty. Liver stiffness measurement before (A) and 24 hours after (B) intervention shows a decrease from 44.1 kPa to 26.4 kPa.


October 6, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), liver stiffness measurements (LSM) obtained by 2D shear-wave elastography (SWE) may serve as a useful quantitative adjunct to Color Doppler ultrasound (CDUS) in monitoring children with chronic Budd-Chiari syndrome (BCS) for disease recurrence after percutaneous interventional treatment.

“LSM decreased significantly after image-guided intervention for chronic BCS in children, showing a maximal decrease at 24 hours post-intervention,” wrote corresponding author Sanjay Sharma from the department of radiodiagnosis and interventional radiology at the All India Institute of Medical Sciences in New Delhi. “Disease recurrence was typically associated with an increase in LSM, compared with the patient’s prior measurement.”

Sharma and team’s prospective study included children with chronic BCS and planned image-guided intervention. CDUS and 2D SWE were performed at baseline; at 24 hours, one month, and three months after intervention; and thereafter every three months or at the time of clinically suspected recurrence.

In the 32 children (28 boys, 4 girls; mean age, 9.0 years) who underwent image-guided intervention for chronic BCS, median LSM was 43.7 kPa at baseline and 22.5 kPa, 18.7 kPa, and 16.7 kPa at 24 hours, one month, and three months, respectively, after intervention. In eight of nine patients with recurrence, LSM was increased, compared with the pre-recurrence measurement.

“The stage of histologic liver fibrosis was not significantly correlated with LSM at any time point, possibly due to the confounding effect of liver congestion,” added the authors of this AJR article.

For more information: www.arrs.org


Related Content

News | Cardiac Imaging

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...

Time October 27, 2025
arrow
News | Endoscopes

Oct. 22, 2025 — Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 ...

Time October 23, 2025
arrow
News | X-Ray

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the ...

Time October 22, 2025
arrow
News | Contrast Media

Oct. 21, 2025 — Subtle Medical, Inc., a provider of AI-powered medical imaging solutions, has announced positive ...

Time October 21, 2025
arrow
News | Artificial Intelligence

Oct. 20, 2025 — Viz.ai has launched of Viz Assist, a suite of autonomous AI agents that significantly enhance how care ...

Time October 20, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Oct. 15, 2025 — GE HealthCare has announced the latest advancement in its Venue family of point-of-care ultrasound ...

Time October 16, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

September 24, 2025—According to the American Journal of Roentgenology (AJR), MRI can reliably identify lateral meniscal ...

Time October 03, 2025
arrow
News | Radiopharmaceuticals and Tracers

Oct. 01, 2025 – Nuclidium AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time October 02, 2025
arrow
News | Radiology Business | Harvey L. Neiman Health Policy Institute

Sept. 30, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that attrition (i.e., exit) from ...

Time October 02, 2025
arrow
News | Ultrasound Women's Health

Sept. 30, 2025 — Sona, the first free, HIPAA-compliant platform that securely delivers ultrasound images directly to ...

Time October 02, 2025
arrow
Subscribe Now